NuvaRing Attorneys Report That Patients May Be Injured
NuvaRing Side Effect Lawsuit
More than 1,500 NuvaRing lawsuits have been filed in various U.S. courts against manufacturer Merck seeking product liability. The plaintiffs have claimed that they suffered from fatal consequences, including strokes, clots, and pulmonary embolism caused by the contraceptive vaginal ring side effects. While over 1,000 federal NuvaRing lawsuits are assigned to Judge Rodney W. Sipple of Missouri eastern district federal court under the MDL provision, about 200 NuvaRing lawsuits are pending in the court of Judge Brian R. Martinotti of Bergen County in New Jersey.
NuvaRing Side Effect: Research Studies Aid Claims
Manufactured by Merck and its subsidiaries – Organon, Schering Plough, and Akzo Nobel – NuvaRing was introduced in the United States in July 2002. The hormonal contraceptive vaginal ring made of flexible polymer contains a combination of progestin and estrogen. Gradual hormonal release inhibits ovulation, while alterations in the cervical mucus stop sperm penetration, leading to prevention of pregnancy. The convenience of self-administration once in a month, without requiring the patient to visit a doctor, makes the contraceptive vaginal ring a popular birth control option.
However, research studies have indicated that serious side effects caused by NuvaRing have forced many to abandon the contraceptive vaginal ring within months after they started using it. Two clinical trial reports prepared following year-long assessments by European and American researchers in 2001 and 2002, acute side effects forced more than 15 percent of users to abandon the birth control device. Consumers experienced obstructive sensation, sexual distress, upper respiratory tract infection, headache, vaginitis, and other side effects.
In June 2012, findings of a Danish study published in the New England Journal of Medicine claimed that NuvaRing birth control could cause two-to-three-fold increase in the possibility of heart attack and stroke. It warned that combination of estrogen and progestine had higher potential of myocardial infarction and ischemic stroke compared to single hormone and non-hormone contraceptives. Based on a comparative study of more than 1.5 million women, the study highlighted that women using NuvaRing were 6.5 times more susceptible to the danger of venous thrombosis. This followed similar findings reported by the British Medical Journal a month ago.
In October 2011, research data released by the FDA warned that NuvaRing birth control users could face an elevated risk of blood clots. The federal sponsored study found that “third generation” progestin hormones used in the contraceptive vaginal ring have 56% higher potential of causing venous thromboembolic events, known as blood clots in the common parlance, when compared to first and second generation progestin. Scholars went through the medical history of 800,000 women to substantiate their claim and found heart attacks and strokes very often in those using NuvaRing birth control device.
NuvaRing Lawsuit: Plaintiffs Claim Serious Complications
According to a NuvaRing birth control lawsuit filed by an Oklahoma woman in January 2013, the plaintiff suffered from bilateral pulmonary emboli or lung arterial blockages following the use of the contraceptive vaginal ring. The birth control device led to blood clots that moved in to her lungs and blocked the arterial path forcing her to be hospitalized. The product liability lawsuit has accused Merck of failing to warn users about the possible NuvaRing side effects, including the risk of life-threatening blood clotting and blockage complications.
A 26-year-old woman suffered a heart stoke because of NuvaRing-induced pulmonary embolism, according to a NuvaRing lawsuit filed in a north Iowa federal court in September 2012. The plaintiff experienced chest pain and breathing problems within a month of using the vaginal ring contraceptive. She had to be hospitalized for six months after a CT scan discovered that she was suffering from pulmonary embolism. In an identical incident, a Californian resident had a near brush with death following NuvaRing-caused blood clot and blockages. Her lawsuit is pending at a Minnesota district court.
In February 2012, a Pennsylvania woman sued Merck for negligence, strict liability, breach of warranty, and fraud. The plaintiff, who had stroke within weeks of using NuvaRing contraceptive, sought punitive as well as compensatory damages for her sufferings.
IF YOU WANT TO LEARN MORE ABOUT HOW WE MAY BE ABLE TO HELP YOU WITH A CLAIM FOR A NUVARING PLEASE CALL US TODAY OR CONTINUE READING.
Side Effects
Some women who have had NuvaRing implanted experienced serious and even debilitating or life-threatening side-effects. Serious side effects that have been linked to NuvaRing include:
- Blood clots
- Cerebral thrombosis
- Deep vein thrombosis (DVT)
- Heart attack or myocardial infarction (MI)
- Pulmonary embolism
- Retinal thrombosis
- Stroke or cerebral hemorrhage
- Thrombophlebitis and venous thrombosis with or without embolism
- Toxic shock syndrome (TSS)
If you experienced adverse NuvaRing side effects or have a loved one who suffered injury following the implantation of NuvaRing, you may have a potential NuvaRing lawsuit.
More Information
Approved by the Food and Drug Administration (FDA) in 2001, NuvaRing is a non-biodegradable, latex-free, flexible vaginal ring containing a combination of the hormones estrogen (ethinyl estradiol) and progestin (etonogestrel). Etonogestrel is the active metabolite of desogestrel, a synthetic form of the naturally occurring female sex hormone progesterone. The NuvaRing contraceptive ring is designed to prevent pregnancy by releasing a steady dose of the hormone combination into the bloodstream through the vaginal walls over the course of 21 days. The hormones prevent ovulation, change the cervical mucus to prevent sperm penetration, and thin the lining of the uterus to, theoretically, prevent sperm implantation.
In October 2003, The New England Journal of Medicine addressed research suggesting that, when taken orally, desogestrel can significantly increase the risk of blood clots. If left untreated, such blood clots can develop into more serious conditions that may include stroke, heart attack, pulmonary embolism, or deep vein thrombosis. These findings, as well as those from other studies, were based upon analysis of the effect of oral contraceptives containing desogestrel.
A Swiss report was released in June 2010 which claimed there were approximately 40 deaths reported in the FDA database of adverse events associated with Nuvaring. The current label and package insert for NuvaRing refers only to studies conducted on women using combination oral contraceptives and suggests that adverse reactions associated with the use of combination hormonal oral contraceptives are likely to apply to combination vaginal contraceptives like NuvaRing. The label, however, states that there is no available epidemiologic data to determine whether the safety and efficacy of vaginal administration of combination hormonal contraceptives differs from oral administration. To date, there is no comprehensive study of NuvaRing and the long-term health effects of its vaginally delivered combination.
Our team of attorneys are now investigating claims and prepared to file NuvaRing lawsuits involving the vaginal ring contraceptive medication NuvaRing®. NuvaRing is manufactured by New Jersey-based Organon USA, Inc., a company that Schering-Plough Corporation acquired in 2007, and has been linked to serious events such as blood clots, pulmonary embolism, stroke and heart attack.Call us today at 1-800-632-1404 for a FREE CONSULTATION.
No Recovery, No Fee
We take NuvaRing litigation cases on a contingency basis. That means that there is no cost to you unless we and our co-counsel are able to recover a settlement or judgment on your behalf. So, unless your case is resolved by trial, arbitration, settlement, or other resolution, you do not have to pay any attorney fees to us, or pay any costs. Litigation costs include filing fees, court reporter fees for deposition, copying costs, experts, and travel. Litigation costs are paid by our firm so you don’t have to have cash to pursue justice against medical device corporations.
About us
Our team of attorneys have been retained by clients across the world as to allegedly defective and improperly designed medical devices and prescription drugs. In fact, our team of attorneys has represented patients around the globe for the allegedly defective Advanced Bionics HiRes90k cochlear implant device and other medical devices including the DePuy hip implant, the Mirena IUD and the transvaginal mesh and transvaginal sling devices including from C.R. Bard, AMS, Boston Scientific and Johnson & Johnson’s Ethicon.
As a NuvaRing attorney, we will investigate your claim and with our co-counsel we stand ready to push your case ahead.
FOR A FREE CASE EVALUATION:
CALL TOLL FREE: (800) 632-1404
EMAIL: clicking here.
FILL OUT THIS FORM FOR FREE HELP:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.